Stocks and Investing
by (remove) : Geulah Livshits
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Geulah Livshits
RSSJSONXMLCSV
Tue, August 13, 2024
Tue, June 18, 2024
Fri, April 5, 2024
Thu, March 21, 2024
Tue, August 15, 2023
Mon, August 14, 2023
Mon, August 7, 2023
Fri, June 30, 2023
Fri, May 12, 2023
Thu, May 11, 2023
Thu, March 30, 2023
Thu, March 23, 2023
Wed, March 22, 2023
Thu, March 9, 2023
Wed, February 1, 2023
Mon, January 30, 2023
Wed, December 7, 2022
Fri, November 11, 2022
Wed, November 9, 2022
Fri, September 23, 2022
Fri, August 12, 2022
Thu, August 11, 2022
Wed, November 3, 2021
Tue, August 24, 2021
Tue, August 17, 2021

Geulah Livshits Maintained (TSHA) at Strong Buy and Held Target at $7 on, Aug 13th, 2024


Published on 2024-10-28 13:36:16 - WOPRAI, Geulah Livshits
  Print publication without navigation


Geulah Livshits of Chardan Capital, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $7 on, Aug 13th, 2024.

Geulah has made no other calls on TSHA in the last 4 months.



There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 0 agree with Geulah's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Geulah


  • Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $6 on, Monday, August 12th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $7 on, Monday, July 1st, 2024
  • Keith Tapper of "BMO Capital" Initiated at Buy and Held Target at $5 on, Thursday, June 27th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Thursday, June 20th, 2024
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Thursday, June 20th, 2024
  • Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $8 on, Tuesday, May 14th, 2024
Contributing Sources